Healthy volunteers needed to test drug equivalence
NCT ID NCT07513649
First seen Apr 08, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study aims to see if two versions of a drug, DA-5230 and DA-5230-R, are absorbed and processed by the body in the same way. It will involve 60 healthy adults aged 19 to 55. Participants will receive a single dose of each drug on separate days, and blood samples will be taken to measure drug levels. This is a Phase 1 trial, meaning it is an early-stage study focused on safety and how the drug behaves in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.